Published in

Bentham Science Publishers, Current Stem Cell Research & Therapy, 1(11), p. 41-50, 2016

DOI: 10.2174/1574888x10666150902095031

Links

Tools

Export citation

Search in Google Scholar

Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder which is characterized by motor neuron (MN) dysfunction, progressive paralysis, and death. Although several therapeutic approaches have been used for treatment of ALS, little success has been resulted. Natural vectors such as mesenchymal stem cells (MSCs) can be a promising tool for overcoming to therapeutic problems. MSCs have multipotential characteristics such as the ability to differentiate into variety of cell types, easy access, immunomodulation, tissue repair, exertion of trophic factors, exosome secretion and efficient homing. In this review, we will discuss the characteristics of MSCs and their possible therapeutic mechanisms in ALS patients.